Search - Université Clermont Auvergne Access content directly

Filter your results

13 Results
authFullName_s : Romain Guièze

Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome

Erin Parry , Ignaty Leshchiner , Romain Guièze , Connor Johnson , Eugen Tausch et al.
Nature Medicine, 2023, 29 (1), pp.158-169. ⟨10.1038/s41591-022-02113-6⟩
Journal articles hal-03950358v1

Real-World Ibrutinib Validation of the Ball Score to Predict Overall Survival: A Filo Group Study in RR CLL Patients

Loic Ysebaert , A.S. Michallet , F. Bijou , A. Clavert , A. Quinquenel et al.
61st Annual Meeting and Exposition of the American Society of Hematology, Dec 2019, Orlando, United States. 134 (Suppl 1), pp.1741, 2019, Blood
Conference poster hal-02427548v1

SnapShot: Chronic Lymphocytic Leukemia

Elisa ten Hacken , Romain Guièze , Catherine J. Wu
Cancer Cell, 2017, 32 (5), pp.716 - 716.e1. ⟨10.1016/j.ccell.2017.10.015⟩
Journal articles hal-01659737v1

Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid Malignancies

Romain Guièze , Vivian Liu , Daniel Rosebrock , Alexis Jourdain , María Hernández-Sánchez et al.
Cancer Cell, 2019, 36 (4), pp.369-384.e13. ⟨10.1016/j.ccell.2019.08.005⟩
Journal articles hal-02318784v1

Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study

Laetitia Largeaud , Pascale Cornillet-Lefebvre , Jean-François Hamel , Pierre-Yves Dumas , Naïs Prade et al.
Leukemia, 2021, 35 (5), pp.1291-1300. ⟨10.1038/s41375-020-01031-1⟩
Journal articles hal-03441014v1

Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL

Romain Guièze , Pauline Robbe , Ruth Clifford , Sophie De Guibert , Bruno Pereira et al.
Blood, 2015, 126 (18), pp.2110--2117. ⟨10.1182/blood-2015-05-647578⟩
Journal articles hal-01263113v1

MCL-1 and PKA/AMPK Axis Fuel Venetoclax Resistance in Lymphoid Cancers

V.M. Liu , Romain Guièze , D. Rosebrock , A.A. Jourdain , M. Hernández-Sánchez et al.
61st Annual Meeting and Exposition of the American Society of Hematology, Dec 2019, Orlando, United States. 134 (Suppl 1), pp.1284, 2019, Blood
Conference poster hal-02427294v1

MNDA controls the expression of MCL-1 and BCL-2 in chronic lymphocytic leukemia cells

Stefania Bottardi , Romain Guièze , Vincent Bourgoin , Nasser Fotouhi-Ardakani , Aurore Douge et al.
Experimental Hematology, 2020, 88, pp.68-82.e5. ⟨10.1016/j.exphem.2020.07.004⟩
Journal articles hal-02935876v1

Autologous and Allogeneic Hematopoietic Stem-Cell Transplantation for Patients with Richter's Syndrome: A Large Series from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation

Olivier Tournilhac , Romain Guièze , D.J. Eikema , N. Zinger , H. Sengeloev et al.
61st Annual Meeting and Exposition of the American Society of Hematology, Dec 2019, Orlando, United States. 134 (Suppl 1), pp.2053, 2019, Blood
Conference poster hal-02427275v1

Clinical and biological characteristics of leukemia cutis in chronic lymphocytic leukemia: A study of the French innovative leukemia organization ( FILO )

Grégory Lazarian , Michaël Munger , Anne Quinquenel , Marie‐sarah Dilhuydy , Lauren Veronese et al.
American Journal of Hematology, 2021, 96 (9), pp.E353-E356. ⟨10.1002/ajh.26274⟩
Journal articles hal-03464731v1

Real-world outcomes following venetoclax therapy in patients with chronic lymphocytic leukemia or Richter syndrome: a FILO study of the French compassionate use cohort

Florian Bouclet , Anne Calleja , Marie-Sarah Dilhuydy , Lauren Véronèse , Bruno Pereira et al.
Annals of Hematology, 2021, 100 (4), pp.987-993. ⟨10.1007/s00277-021-04419-w⟩
Journal articles hal-03441025v1

Addition of Lomustine (CCNU) to Induction and Post-Remission Chemotherapy for Fit Elderly AML Patients without Unfavorable Cytogenetics: Results of the Lamsa-2007 Goelams Trial

Arnaud Pigneux , Christian Récher , Marie C. Bene , Julien Asselineau , Ariane C. Mineur et al.
Blood, 2015, 126 (23)
Journal articles hal-01295674v1
Image document

Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study

Laetitia Largeaud , Pascale Cornillet-Lefebvre , Jean-François Hamel , Pierre-Yves Dumas , Naïs Prade et al.
Leukemia, 2021, 35 (5), pp.1291-1300. ⟨10.1038/s41375-020-01031-1⟩
Journal articles hal-03623649v1